Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
Public ClinicalTrials.gov record NCT04505436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH
Study identification
- NCT ID
- NCT04505436
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 215 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2020
- Primary completion
- Jun 26, 2026
- Completion
- Jul 26, 2026
- Last update posted
- Jun 29, 2026
2020 – 2026
United States locations
- U.S. sites
- 48
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Alabama GI Research Center | Huntsville | Alabama | 35801 | — |
| Synexus US - Chandler | Chandler | Arizona | 85224 | — |
| Precision Research Institute, LLC. (PRI) | Chula Vista | California | 91910 | — |
| Fresno Clinical Research Center | Fresno | California | 93720 | — |
| NAFLD Research Center - Altman Clinical and Translational Research Institute | La Jolla | California | 92037 | — |
| UC Davis Health System - Midtown Ambulatory Care Center | Sacramento | California | 95816 | — |
| University of Florida College of Medicine | Gainesville | Florida | 32610 | — |
| Schiff Center for Liver Diseases - University of Miami Leonard M. Miller School of Medicine(UMMSM) | Miami | Florida | 33136 | — |
| San Marcus Research Clinic | Miami Lakes | Florida | 330145602 | — |
| Floridian Clinical Research, LLC | Miami Lakes | Florida | 33016 | — |
| Ocala GI Research | Ocala | Florida | 34471 | — |
| Synexus Clinical Research US, Inc. - Orlando | Orlando | Florida | 32806 | — |
| Synexus Clinical Research US, Inc. - The Villages | The Villages | Florida | 32162 | — |
| Synexus Clinical Research US, Inc | Chicago | Illinois | 60602 | — |
| Gastroenterology Health Partners, PLLC - Southern Indiana | New Albany | Indiana | 47150 | — |
| Kansas Medical Clinic PA (KMC) - Gastrointestinal Medical Plaza | Topeka | Kansas | 66606-1707 | — |
| Tandem Clinical Research, LLC | Marrero | Louisiana | 70072 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Mercy Medical Center - The Institute for Digestive Health and Liver Disease | Baltimore | Maryland | 21202-2102 | — |
| Brigham and Women's hospital | Boston | Massachusetts | 02115 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202-2608 | — |
| West Michigan Clinical Research Center | Wyoming | Michigan | 49519 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Nevada Family Care & Wellness Center | Henderson | Nevada | 89052 | — |
| Tandem Clinical Research, LLC | New York | New York | 10033 | — |
| UNC Health Care System | Chapel Hill | North Carolina | 27514 | — |
| Carolinas Center for Liver Disease, Carolinas HealthCare System/Atrium Health | Charlotte | North Carolina | 28204 | — |
| Duke University Medical Center | Durham | North Carolina | 27710-4000 | — |
| Lucas Research | Morehead City | North Carolina | 28557 | — |
| Consultants for Clinical Research | Liberty Township | Ohio | 45044 | — |
| University of Pittsburgh Medical Center (UPMC) - The Center for Liver Diseases | Pittsburgh | Pennsylvania | 15213 | — |
| ClinSearch | Chattanooga | Tennessee | 37421 | — |
| Texas Clinical Research Institute, LLC | Arlington | Texas | 76012 | — |
| Texas Liver Institute (TLI) - Texas Metabolic Center | Austin | Texas | 78757-7571 | — |
| The Liver Institute at Methodist Dallas | Dallas | Texas | 75203 | — |
| Dallas Diabetes and Endocrine Center | Dallas | Texas | 75230 | — |
| Liver Center of Texas, PLLC | Dallas | Texas | 75234 | — |
| Synexus Clinical Research US, Inc | Dallas | Texas | 75234 | — |
| Digestive Health Associates of Texas, P.A. (DHAT) | Garland | Texas | 75044 | — |
| Baylor College of Medicine - Advanced Liver Therapies | Houston | Texas | 77030 | — |
| Centex Studies, Inc. | Houston | Texas | 77058 | — |
| Pioneer Research Solutions Inc | Houston | Texas | 77099-4307 | — |
| American Research Corporation at the Texas Liver Institute | San Antonio | Texas | 78215 | — |
| University of Utah Health Care - UUHC - Kidney & Liver Clinic | Salt Lake City | Utah | 84132 | — |
| Bon Secours Liver Institute of Virginia - Newport News | Newport News | Virginia | 23602 | — |
| Virginia Commonwealth University (VCU) Medical Center | Richmond | Virginia | 23298 | — |
| University of Washington (UW) - Harborview Medical Center (HMC) - Hepatitis and Liver Clinic | Seattle | Washington | 98104 | — |
| Liver Institute Northwest | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
Recently updated NASH - Nonalcoholic Steatohepatitis trials
Other public records listing NASH - Nonalcoholic Steatohepatitis. Sorted by last update posted; newest first. Not a recommendation.
- NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) Active, not recruiting
- NCT04054310: Non-Invasive Quantification of Liver Health in NASH (N-QUAN) Recruiting
- NCT03900429: A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis Active, not recruiting
- NCT03587831: Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis Recruiting
- NCT05165446: Novel MRE Technique to Assess a Risk Factor for Liver Cancer Active, not recruiting
- NCT04383951: Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04505436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2026 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04505436 live on ClinicalTrials.gov.